great post @KingBuzzo get some thinking… so if Amgen do nothing lose patent life and becomes a generic. If P2 CPACS gets accelerated approval. Could Race no simply pair with generic off label and patent?
what is more likely, Amgen find some other combo that improves anti-cancer perhaps increasing side effects.
Pairs with Bisantrene so anti-cancer and cardio protect exclusivity and increases MTD.
When do we hear from Amgen next? My thinking is after P1 readouts. It’s also a foot in the door of Amgen want CPACS+Dox
- Forums
- ASX - By Stock
- RAC
- Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model
Ann: Bisantrene Highly Active in a Multiple Myeloma Mouse Model, page-55
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.75 |
Change
0.010(0.57%) |
Mkt cap ! $298.0M |
Open | High | Low | Value | Volume |
$1.73 | $1.83 | $1.73 | $272.0K | 152.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | $1.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.79 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9998 | 1.750 |
1 | 7599 | 1.730 |
1 | 581 | 1.720 |
3 | 11557 | 1.710 |
4 | 46280 | 1.700 |
Price($) | Vol. | No. |
---|---|---|
1.790 | 2000 | 1 |
1.830 | 44030 | 2 |
1.840 | 10500 | 2 |
1.850 | 14500 | 3 |
1.860 | 949 | 2 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |